$ELIQQ
Electriq Power Holdings, Inc. Stock $eliqq

$eliqq Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000162828023038999 Filed on November 14, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q4
Revenue		$834.3K	$0.00
YoY Change
Cost Of Revenue		$853.6K
YoY Change		-84.82%
Gross Profit		-$19.35K
YoY Change		-105.28%
Gross Profit Margin		-2.32%
Selling, General & Admin		$6.116M	$2.589M
YoY Change		249.91%	154.02%
% of Gross Profit
Research & Development		$1.012M
YoY Change		12.27%
% of Gross Profit
Depreciation & Amortization		$42.49K
YoY Change		34.98%
% of Gross Profit
Operating Expenses		$7.127M	$2.589M
YoY Change		307.79%	154.02%
Operating Profit		-$7.147M
YoY Change		308.9%
Interest Expense		$1.292M	$4.165M
YoY Change		-46.35%	32.59%
% of Operating Profit
Other Income/Expense, Net		$3.380M
YoY Change		-76434.46%
Pretax Income		-$19.95M	$1.575M
YoY Change		-3122.11%	-25.75%
Income Tax		$0.00	$628.8K
% Of Pretax Income			39.92%
Net Earnings		-$19.95M	$946.5K
YoY Change		-6955.28%	-55.39%
Net Earnings / Revenue		-2391.75%
Basic Earnings Per Share		-$0.74
Diluted Earnings Per Share		-$0.74	$0.02
COMMON SHARES
Basic Shares Outstanding	41.75M shares	38.12M
Diluted Shares Outstanding		26.94M shares

Balance Sheet

Concept	2023 Q3	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.100M	$19.75K
YoY Change	3242.86%	-59.27%
Cash & Equivalents	$8.100M	$19.75K
Short-Term Investments
Other Short-Term Assets	$990.5K	$108.2K
YoY Change	139.75%	2.38%
Inventory	$20.93M	$13.53M
Prepaid Expenses		$108.2K
Receivables	$371.9K	$317.4K
Other Receivables	$0.00
Total Short-Term Assets	$32.49M	$127.9K
YoY Change	4857.47%	-17.02%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.731M	$1.422M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$131.3K	$80.95M
YoY Change	-99.97%	-79.76%
Total Long-Term Assets	$5.209M	$80.95M
YoY Change	-98.7%	-79.76%
TOTAL ASSETS
Total Short-Term Assets	$32.49M	$127.9K
Total Long-Term Assets	$5.209M	$80.95M
Total Assets	$37.70M	$81.07M
YoY Change	-90.64%	-79.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.201M	$276.9K
YoY Change	4802.47%	466.1%
Accrued Expenses	$2.295M	$4.472M
YoY Change	-17.16%	84.13%
Deferred Revenue	$326.0K	$192.0K
YoY Change
Short-Term Debt	$0.00	$2.330M
YoY Change	-100.0%	153.3%
Long-Term Debt Due	$0.00
YoY Change
Total Short-Term Liabilities	$13.45M	$8.135M
YoY Change	116.4%	131.17%
LONG-TERM LIABILITIES
Long-Term Debt	$21.47M	$0.00
YoY Change
Other Long-Term Liabilities	$2.605M	$14.80M
YoY Change	-82.63%	-39.84%
Total Long-Term Liabilities	$2.605M	$14.80M
YoY Change	-82.63%	-39.84%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.45M	$8.135M
Total Long-Term Liabilities	$2.605M	$14.80M
Total Liabilities	$40.56M	$22.94M
YoY Change	91.18%	-18.44%
SHAREHOLDERS EQUITY
Retained Earnings	-$118.5M	-$21.60M
YoY Change	493.68%	-22.69%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$42.38M	-$21.60M
YoY Change
Total Liabilities & Shareholders Equity	$37.70M	$81.07M
YoY Change	-90.64%	-79.74%

Cashflow Statement

Concept	2023 Q3	2022 Q4
OPERATING ACTIVITIES
Net Income	-$19.95M	$946.5K
YoY Change	-6955.28%	-55.39%
Depreciation, Depletion And Amortization	$42.49K
YoY Change	34.98%
Cash From Operating Activities	-$9.047M	-$502.5K
YoY Change	7031.81%	48.19%
INVESTING ACTIVITIES
Capital Expenditures	$261.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$1.910K	$324.4M
YoY Change	-100.6%
Cash From Investing Activities	-$262.9K	$324.4M
YoY Change	-182.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	13.03M	-324.2M
YoY Change		-92717.75%
NET CHANGE
Cash From Operating Activities	-9.047M	-502.5K
Cash From Investing Activities	-262.9K	324.4M
Cash From Financing Activities	13.03M	-324.2M
Net Change In Cash	3.723M	-222.5K
YoY Change	1827.19%	-2147.38%
FREE CASH FLOW
Cash From Operating Activities	-$9.047M	-$502.5K
Capital Expenditures	$261.0K
Free Cash Flow	-$9.308M
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	City Area Code CityAreaCode	833
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0388
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.7152
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.7165
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.7165
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.7353
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	dei	Entity Central Index Key EntityCentralIndexKey	0001827871
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P3M
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2022Q1	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2022Q3	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P2Y
CY2023Q3	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Registrant Name EntityRegistrantName	ELECTRIQ POWER HOLDINGS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-3310839
	dei	Entity Address Address Line1 EntityAddressAddressLine1	625 North Flagler Drive,
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1003B
	dei	Entity Address City Or Town EntityAddressCityOrTown	West Palm Beach,
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33401
	dei	Local Phone Number LocalPhoneNumber	462-2883
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	41754345	shares
CY2023Q3	us-gaap	Cash Cash	8099738	usd
CY2022Q4	us-gaap	Cash Cash	5480960	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	40449	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	30429	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	371923	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	317423	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	20929486	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	13532475	usd
CY2023Q3	eltq	Inventory Deposits Current InventoryDepositsCurrent	238068	usd
CY2022Q4	eltq	Inventory Deposits Current InventoryDepositsCurrent	5182045	usd
CY2023Q3	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	2101424	usd
CY2022Q4	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	0	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	752391	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	368117	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	32493030	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	24881020	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1730670	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1422293	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3346958	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3241705	usd
CY2023Q3	us-gaap	Deposits Assets DepositsAssets	131257	usd
CY2022Q4	us-gaap	Deposits Assets DepositsAssets	109539	usd
CY2023Q3	us-gaap	Assets Assets	37701915	usd
CY2022Q4	us-gaap	Assets Assets	29654557	usd
CY2023Q3	us-gaap	Loans Payable Current LoansPayableCurrent	0	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	11377297	usd
CY2023Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	0	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	51600000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	8201251	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1377123	usd
CY2023Q3	eltq	Warrant Liability Current WarrantLiabilityCurrent	0	usd
CY2022Q4	eltq	Warrant Liability Current WarrantLiabilityCurrent	14114411	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2233598	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	629773	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	718027	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	347131	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2294996	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5196432	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	13447872	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	84642167	usd
CY2023Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	3039603	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	0	usd
CY2023Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	0	usd
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	5000000	usd
CY2023Q3	us-gaap	Mandatorily Redeemable Preferred Stock Fair Value Disclosure MandatorilyRedeemablePreferredStockFairValueDisclosure	21465335	usd
CY2022Q4	us-gaap	Mandatorily Redeemable Preferred Stock Fair Value Disclosure MandatorilyRedeemablePreferredStockFairValueDisclosure	0	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2605293	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2503038	usd
CY2023Q3	us-gaap	Liabilities Liabilities	40558103	usd
CY2022Q4	us-gaap	Liabilities Liabilities	92145205	usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	3734062	shares
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2023Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	39523511	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38020283	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38020283	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21902477	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21902477	shares
CY2023Q3	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	3802	usd
CY2022Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	2190	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	76075014	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	42500855	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-118458233	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-104993411	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-282	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-282	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-42379699	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-62490648	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	37701915	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	29654557	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	834262	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5988248	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1019207	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15334583	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	853615	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5621589	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1921367	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	13957964	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	-19353	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	366659	usd
	us-gaap	Gross Profit GrossProfit	-902160	usd
	us-gaap	Gross Profit GrossProfit	1376619	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1011633	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	901058	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3147943	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2716351	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1308928	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	909871	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3522731	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2790657	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4806693	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2626179	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14235262	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6975600	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	7127254	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	4437108	usd
	us-gaap	Operating Expenses OperatingExpenses	20905936	usd
	us-gaap	Operating Expenses OperatingExpenses	12482608	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-7146607	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4070449	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-21808096	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-11105989	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	1291851	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	918035	usd
	us-gaap	Interest Expense InterestExpense	3292932	usd
	us-gaap	Interest Expense InterestExpense	1223254	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-14895081	usd
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-5170186	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	10891144	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-32128614	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3380090	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4428	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	745062	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5864	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19953449	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10163098	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13464822	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-44463721	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-19953449	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-10163098	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13464822	usd
	us-gaap	Net Income Loss NetIncomeLoss	-44463721	usd
CY2023Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	45803	usd
CY2022Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	451895	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	978752	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	1283334	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-19999252	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10614993	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14443574	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-45747055	usd
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.74
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.74
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.65
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.65
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.40
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.40
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-29.57
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-29.57
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26944552	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26944552	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1595724	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1595724	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10290182	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10290182	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1546928	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1546928	shares
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
	eltq	Temporary Equity Stock Issued During Period Value New Issues Contingently Redeemable TemporaryEquityStockIssuedDuringPeriodValueNewIssuesContingentlyRedeemable	37560166	usd
	us-gaap	Reclassifications Of Temporary To Permanent Equity ReclassificationsOfTemporaryToPermanentEquity	-548595	usd
	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	2511940	usd
CY2023Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	39523511	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-62490648	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	26340	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1515816	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10032916	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-70981408	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	14360522	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1280436	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	16521543	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-38818907	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4855686	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	2185254	usd
CY2023Q3	eltq	Stock Issued During Period Value Stock Splits StockIssuedDuringPeriodValueStockSplits	-26185162	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1600000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	362	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	548595	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	493117	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-19953449	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-42379699	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-23160308	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2347	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	138007	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-7937071	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-30957025	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	12134	usd
CY2022Q2	eltq	Stock Issued During Period Value New Issues Warrants StockIssuedDuringPeriodValueNewIssuesWarrants	10625991	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	339821	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-26363552	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-46342631	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	53556	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	287430	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-10163098	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-56164743	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13464822	usd
	us-gaap	Net Income Loss NetIncomeLoss	-44463721	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3289369	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	765258	usd
	us-gaap	Accretion Expense AccretionExpense	1319145	usd
	us-gaap	Accretion Expense AccretionExpense	0	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	10891144	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-32128614	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	123308	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	119388	usd
	eltq	Operating Lease Amortization Expense OperatingLeaseAmortizationExpense	507511	usd
	eltq	Operating Lease Amortization Expense OperatingLeaseAmortizationExpense	163626	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	5641658	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	usd
	us-gaap	Inventory Write Down InventoryWriteDown	5040689	usd
	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	54500	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	963629	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1853445	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4119767	usd
	eltq	Increase Decrease In Inventory Deposits IncreaseDecreaseInInventoryDeposits	96712	usd
	eltq	Increase Decrease In Inventory Deposits IncreaseDecreaseInInventoryDeposits	2488479	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	384274	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	23948	usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	21718	usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	900160	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	6660128	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-630627	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-7274682	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	1851794	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-470168	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	210976	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-23212973	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18350675	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	431685	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	834132	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	4923	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	3798	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-436608	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-837930	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	11200000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	3584989	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1333027	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	3500000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
	eltq	Proceeds Received From Business Combination ProceedsReceivedFromBusinessCombination	1820	usd
	eltq	Proceeds Received From Business Combination ProceedsReceivedFromBusinessCombination	0	usd
	us-gaap	Proceeds From Issuance Of Redeemable Preferred Stock ProceedsFromIssuanceOfRedeemablePreferredStock	9550792	usd
	us-gaap	Proceeds From Issuance Of Redeemable Preferred Stock ProceedsFromIssuanceOfRedeemablePreferredStock	0	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	693000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	17439776	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	95614	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	594040	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-45000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-40000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	26268359	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10615587	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2618778	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-8573018	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5480960	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12730198	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8099738	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4157180	usd
	us-gaap	Interest Paid Net InterestPaidNet	1601660	usd
	us-gaap	Interest Paid Net InterestPaidNet	130890	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	787764	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1200086	usd
	us-gaap	Stock Issued1 StockIssued1	24787728	usd
	us-gaap	Stock Issued1 StockIssued1	0	usd
	eltq	Conversion And Exchange Of Warrants For Shares Of Class A Common Stock ConversionAndExchangeOfWarrantsForSharesOfClassACommonStock	2185254	usd
	eltq	Conversion And Exchange Of Warrants For Shares Of Class A Common Stock ConversionAndExchangeOfWarrantsForSharesOfClassACommonStock	0	usd
	eltq	Recapitalization On Conversion Of Pre2023 Seed Preferred To Class A Common Stock RecapitalizationOnConversionOfPre2023SeedPreferredToClassACommonStock	34792203	usd
	eltq	Recapitalization On Conversion Of Pre2023 Seed Preferred To Class A Common Stock RecapitalizationOnConversionOfPre2023SeedPreferredToClassACommonStock	0	usd
	eltq	Increase Decrease In Loans Payable IncreaseDecreaseInLoansPayable	-11377297	usd
	eltq	Increase Decrease In Loans Payable IncreaseDecreaseInLoansPayable	-1333027	usd
	eltq	Loan Payable Principal Payments LoanPayablePrincipalPayments	-3584989	usd
	eltq	Loan Payable Principal Payments LoanPayablePrincipalPayments	-1333027	usd
CY2023Q3	eltq	Temporary Equity Dividend Rate Percentage TemporaryEquityDividendRatePercentage	0.15
CY2023Q2	eltq	Reverse Capitalization Pre Close Financing Amount ReverseCapitalizationPreCloseFinancingAmount	18100000	usd
CY2023Q3	eltq	Stock Issued Nonredemption Reverse Recapitalization StockIssuedNonredemptionReverseRecapitalization	211797	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38120937	shares
CY2023Q3	us-gaap	Other Payments To Acquire Businesses OtherPaymentsToAcquireBusinesses	37261790	usd
CY2023Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.63
CY2023Q3	eltq	Reverse Recapitalization Consideration Transferred Cash Balance ReverseRecapitalizationConsiderationTransferredCashBalance	84471539	usd
CY2023Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	40072106	usd
CY2023Q3	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	82220659	usd
CY2023Q3	eltq	Reverse Recapitalization Forward Purchase Contract Asset Issuance Costs ReverseRecapitalizationForwardPurchaseContractAssetIssuanceCosts	200000	usd
CY2023Q3	us-gaap	Other Payments To Acquire Businesses OtherPaymentsToAcquireBusinesses	37261790	usd
CY2023Q3	eltq	Reverse Recapitalization Pre Close Transaction Costs ReverseRecapitalizationPreCloseTransactionCosts	5059376	usd
CY2023Q3	eltq	Cash Acquired Through Reverse Recapitalization Net CashAcquiredThroughReverseRecapitalizationNet	1820	usd
CY2023Q3	eltq	Reverse Recapitalization Contingent Consideration Liabilities Assumed ReverseRecapitalizationContingentConsiderationLiabilitiesAssumed	6646468	usd
CY2023Q3	eltq	Reverse Recapitalization Consideration Transferred Cumulative Mandatorily Redeemable Stock ReverseRecapitalizationConsiderationTransferredCumulativeMandatorilyRedeemableStock	4186797	usd
CY2023Q3	eltq	Reverse Recapitalization Consideration Transferred Warrants ReverseRecapitalizationConsiderationTransferredWarrants	10160000	usd
CY2023Q3	eltq	Reverse Recapitalization Consideration Transferred Contingently Redeemable Common Shares ReverseRecapitalizationConsiderationTransferredContingentlyRedeemableCommonShares	3000000	usd
CY2023Q3	eltq	Reverse Recapitalization Consideration Transferred Equity Issuance Costs On Forward Purchase Contract Asset ReverseRecapitalizationConsiderationTransferredEquityIssuanceCostsOnForwardPurchaseContractAsset	594040	usd
CY2023Q3	eltq	Reverse Recapitalization Consideration Transferred Warrants Fair Value ReverseRecapitalizationConsiderationTransferredWarrantsFairValue	1600000	usd
CY2023Q3	eltq	Reverse Recapitalization Net ReverseRecapitalizationNet	26185485	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-118458233	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Significant estimates and assumptions include the useful lives of property and equipment; inventory; stock-based compensation; warrants; derivatives; preferred stock; Forward Purchase Agreement; Simple Agreement for Future Equity (“SAFE”) notes; convertible notes; income taxes; and reserves for warranties.</span></div>
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	40449	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	30429	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	10020	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	72791	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	89196	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	263784	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023Q3	us-gaap	Advertising Expense AdvertisingExpense	440618	usd
CY2022Q3	us-gaap	Advertising Expense AdvertisingExpense	148215	usd
	us-gaap	Advertising Expense AdvertisingExpense	1122791	usd
	us-gaap	Advertising Expense AdvertisingExpense	628826	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risks and Other Risks and Uncertainties</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments potentially subjecting the Company to concentrations of credit risk consist principally of cash and accounts receivable. Cash is mainly deposited on demand at one financial institution in the U.S. At times, such deposits may be in excess of insured limits. The Company has not experienced any losses on its deposits of cash.</span></div>The Company’s accounts receivables are derived from revenue earned from customers located throughout the world. When necessary, the Company performs credit evaluations of its customers’ financial condition and sometimes requires partial payment in advance of shipping.
CY2023Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	3734062	shares
	us-gaap	Derivatives Embedded Derivatives DerivativesEmbeddedDerivatives	<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Embedded Derivatives</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for embedded derivatives at fair value in accordance with ASC 815-15, Derivatives and Hedging; Embedded Derivatives. Embedded derivatives that are required to be bifurcated from the underlying host instrument are accounted for and valued as a separate financial instrument.</span></div>
	eltq	Standard Product Warranty Term StandardProductWarrantyTerm	P10Y
	eltq	Standard Product Warranty Maximum Megawatt Hour Used Threshold To Cancel Warranty StandardProductWarrantyMaximumMegawattHourUsedThresholdToCancelWarranty	7.52	mwh
CY2023Q3	eltq	Cumulative Mandatorily Redeemable Preferred Stock Original Issue Price CumulativeMandatorilyRedeemablePreferredStockOriginalIssuePrice	10
CY2023Q2	eltq	Financial Instruments Subject To Mandatory Redemption Settlement Terms Dividend Percentage FinancialInstrumentsSubjectToMandatoryRedemptionSettlementTermsDividendPercentage	0.15
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	192012	usd
CY2023Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	340725	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	436860	usd
CY2023Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1987124	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	976881	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	21176061	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	23260226	shares
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	834262	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5988248	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1019207	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15334583	usd
CY2023Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	412372	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	347852	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	325993	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	628872	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	446360	usd
	eltq	Contract With Customer Liability Increase From Billings ContractWithCustomerLiabilityIncreaseFromBillings	1057053	usd
	eltq	Contract With Customer Liability Increase From Billings ContractWithCustomerLiabilityIncreaseFromBillings	15517008	usd
	eltq	Contract With Customer Liability Revenue Recognized Excluding Opening Balance ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance	1019207	usd
	eltq	Contract With Customer Liability Revenue Recognized Excluding Opening Balance ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance	15334583	usd
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	666718	usd
CY2022Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	628785	usd
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	296788	usd
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	38940	usd
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	38940	usd
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	38940	usd
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	38940	usd
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	214170	usd
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	666718	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2090005	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1659366	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	359335	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	237073	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1730670	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1422293	usd
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	42492	usd
CY2022Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	31480	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	123308	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	119388	usd
CY2023Q2	eltq	Proceeds From Pre Close Financing And Debt Conversion ProceedsFromPreCloseFinancingAndDebtConversion	21130000	usd
CY2023Q2	eltq	Reverse Capitalization Pre Close Financing Amount ReverseCapitalizationPreCloseFinancingAmount	11000000	usd
CY2023Q3	eltq	Debt Amount Converted Or Paid DebtAmountConvertedOrPaid	11200000	usd
CY2023Q3	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	551105	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	832283	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	325993	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	192012	usd
CY2023Q3	us-gaap	Interest Payable Current InterestPayableCurrent	0	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1961477	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1417898	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2210660	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2294996	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5196432	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	832283	usd
CY2021Q4	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	1029862	usd
	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	19785	usd
	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	307732	usd
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	300963	usd
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	481819	usd
CY2023Q3	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	551105	usd
CY2022Q3	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	855775	usd
CY2022Q1	eltq	Lessee Operating Lease Number Of Renewal Options LesseeOperatingLeaseNumberOfRenewalOptions	5	renewal_option
CY2022Q1	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P1Y
CY2022Q1	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P4Y
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1700000	usd
CY2022Q1	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.190
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1400000	usd
CY2022Q1	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P5Y
CY2022Q1	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P5Y
CY2022Q1	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.190
CY2022Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P5Y
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	800000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P5Y
CY2022Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P5Y
CY2022Q3	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.190
CY2023Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P39M
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1100000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P39M
CY2023Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.190
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y4M24D
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	276635	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1246533	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1285664	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	771571	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	420362	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4000765	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1025601	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	2975164	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3346958	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	718027	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2257137	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3241705	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	347131	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2058734	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	428913	usd
CY2022Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	146044	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1098759	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	460056	usd
CY2023Q3	us-gaap	Inventory Write Down InventoryWriteDown	2383408	usd
	us-gaap	Inventory Write Down InventoryWriteDown	5040689	usd
CY2023Q3	us-gaap	Inventory Write Down InventoryWriteDown	2383408	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	30000000	shares
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q2	eltq	Reverse Capitalization Pre Close Financing Amount ReverseCapitalizationPreCloseFinancingAmount	18100000	usd
CY2023Q2	eltq	Reverse Capitalization Pre Close Financing Amount ReverseCapitalizationPreCloseFinancingAmount	11000000	usd
CY2023Q3	eltq	Reverse Capitalization Pre Close Financing Amount ReverseCapitalizationPreCloseFinancingAmount	7100000	usd
CY2023Q3	eltq	Reverse Capitalization Pre Close Financing Amount ReverseCapitalizationPreCloseFinancingAmount	18100000000000	usd
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	2589818	shares
CY2023Q3	eltq	Cumulative Mandatorily Redeemable Preferred Stock Original Issue Price CumulativeMandatorilyRedeemablePreferredStockOriginalIssuePrice	10
CY2023Q2	eltq	Financial Instruments Subject To Mandatory Redemption Settlement Terms Dividend Percentage FinancialInstrumentsSubjectToMandatoryRedemptionSettlementTermsDividendPercentage	0.15
CY2023Q3	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Carrying Amount RedeemableNoncontrollingInterestEquityPreferredCarryingAmount	21465334	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0143
CY2023Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	39523511	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2023Q3	eltq	Temporary Equity Fair Value Disclosure TemporaryEquityFairValueDisclosure	6571949	usd
CY2022Q4	eltq	Temporary Equity Fair Value Disclosure TemporaryEquityFairValueDisclosure	0	usd
	eltq	Temporary Equity Dividend Rate Percentage TemporaryEquityDividendRatePercentage	0.08
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022	eltq	Reverse Recapitalization Common Stock Shares Reversed ReverseRecapitalizationCommonStockSharesReversed	-242302003	shares
CY2021	eltq	Reverse Recapitalization Common Stock Shares Reversed ReverseRecapitalizationCommonStockSharesReversed	-217588804	shares
CY2022	eltq	Common Stock Shares Outstanding At Exchange Ratio CommonStockSharesOutstandingAtExchangeRatio	1837507	shares
CY2021	eltq	Common Stock Shares Outstanding At Exchange Ratio CommonStockSharesOutstandingAtExchangeRatio	1650094	shares
CY2022	eltq	Preferred Stock Shares Outstanding At Exchange Ratio PreferredStockSharesOutstandingAtExchangeRatio	16537692	shares
CY2021	eltq	Preferred Stock Shares Outstanding At Exchange Ratio PreferredStockSharesOutstandingAtExchangeRatio	15924999	shares
CY2022	eltq	Common Stock Shares Issued For Anti Dilution Factor CommonStockSharesIssuedForAntiDilutionFactor	2997836	shares
CY2021	eltq	Common Stock Shares Issued For Anti Dilution Factor CommonStockSharesIssuedForAntiDilutionFactor	2821323	shares
CY2022Q4	eltq	Reverse Recapitalization Common Stock Shares Outstanding ReverseRecapitalizationCommonStockSharesOutstanding	21373035	shares
CY2021Q4	eltq	Reverse Recapitalization Common Stock Shares Outstanding ReverseRecapitalizationCommonStockSharesOutstanding	20396416	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	eltq	Reverse Capitalization Required Conversion Of Shareholder Notes Amount ReverseCapitalizationRequiredConversionOfShareholderNotesAmount	10130000	usd
CY2023Q2	eltq	Reverse Capitalization Pre Close Financing Amount ReverseCapitalizationPreCloseFinancingAmount	18100000	usd
CY2023Q2	eltq	Reverse Capitalization Pre Close Financing Amount ReverseCapitalizationPreCloseFinancingAmount	11000000	usd
CY2023Q3	eltq	Reverse Capitalization Pre Close Financing Amount ReverseCapitalizationPreCloseFinancingAmount	7100000	usd
CY2023Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	360603	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38120937	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38120937	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38020283	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38020283	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21902477	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21902477	shares
CY2023Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	3734062	shares
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3146295	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	435409	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	41709	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	548343	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.61
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	10.62
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0353
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0427
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1151710	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.84
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y9M18D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	41709	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	9.23
	eltq	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm	P10Y
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	64860	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.86
	eltq	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageRemainingContractualTerm	P8Y9M18D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	41828	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.19
	eltq	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodWeightedAverageRemainingContractualTerm	P8Y6M
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1086731	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.15
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y1M6D
CY2023Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	1086731	shares
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P7Y9M18D
CY2023Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	887132	shares
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P8Y
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	139637	shares
CY2023Q3	eltq	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Initial Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedInitialExercisePrice	111063	usd
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	344285	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	801102	shares
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	7.26
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	8.65
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	285713	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	287430	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3081964	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	765257	usd
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1963762	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y9M18D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	661940	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	14319711	usd
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	843193	usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	6662522	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	537764	usd
CY2023Q3	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	2101424	usd
CY2023Q3	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	2101424	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	65714411	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	1500000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	37072106	usd
	us-gaap	Fair Value Assets And Liabilities Measured On Recurring Basis Gain Loss Included In Earnings FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarnings	10891144	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-8660000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases Sales Issuances Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements	26972982	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	938179	usd
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	43917684	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-32128614	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases Sales Issuances Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements	9932991	usd
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	66113307	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
eltq-20230930_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
eltq-20230930_cal.xml	Edgar Link	unprocessable
0001628280-23-038999-index-headers.html	Edgar Link	pending
0001628280-23-038999-index.html	Edgar Link	pending
0001628280-23-038999.txt	Edgar Link	pending
0001628280-23-038999-xbrl.zip	Edgar Link	pending
a691367696_v3xeliq-ex311.htm	Edgar Link	pending
a691368147_v3xeliq-ex312.htm	Edgar Link	pending
a691368339_v3xeliq-ex321.htm	Edgar Link	pending
a691368538_v3xeliq-ex322.htm	Edgar Link	pending
electriq-arregistrationr.htm	Edgar Link	pending
electriq-arregistrationr001.jpg	Edgar Link	pending
electriq-arregistrationr002.jpg	Edgar Link	pending
electriq-arregistrationr003.jpg	Edgar Link	pending
electriq-arregistrationr004.jpg	Edgar Link	pending
electriq-arregistrationr005.jpg	Edgar Link	pending
electriq-arregistrationr006.jpg	Edgar Link	pending
electriq-arregistrationr007.jpg	Edgar Link	pending
electriq-arregistrationr008.jpg	Edgar Link	pending
electriq-arregistrationr009.jpg	Edgar Link	pending
electriq-arregistrationr010.jpg	Edgar Link	pending
electriq-arregistrationr011.jpg	Edgar Link	pending
electriq-arregistrationr012.jpg	Edgar Link	pending
electriq-arregistrationr013.jpg	Edgar Link	pending
electriq-arregistrationr014.jpg	Edgar Link	pending
electriq-arregistrationr015.jpg	Edgar Link	pending
electriq-arregistrationr016.jpg	Edgar Link	pending
electriq-arregistrationr017.jpg	Edgar Link	pending
electriq-arregistrationr018.jpg	Edgar Link	pending
electriq-arregistrationr019.jpg	Edgar Link	pending
electriq-arregistrationr020.jpg	Edgar Link	pending
electriq-arregistrationr021.jpg	Edgar Link	pending
electriq-arregistrationr022.jpg	Edgar Link	pending
electriq-arregistrationr023.jpg	Edgar Link	pending
electriq-arregistrationr024.jpg	Edgar Link	pending
electriq-arregistrationr025.jpg	Edgar Link	pending
electriq-arregistrationr026.jpg	Edgar Link	pending
electriq-arregistrationr027.jpg	Edgar Link	pending
electriq-arregistrationr028.jpg	Edgar Link	pending
electriq-arregistrationr029.jpg	Edgar Link	pending
electriq-arregistrationr030.jpg	Edgar Link	pending
electriq-arregistrationr031.jpg	Edgar Link	pending
electriq-arregistrationr032.jpg	Edgar Link	pending
electriq-arregistrationr033.jpg	Edgar Link	pending
electriq-arregistrationr034.jpg	Edgar Link	pending
electriq-stockholdersagr.htm	Edgar Link	pending
electriq-stockholdersagr001.jpg	Edgar Link	pending
electriq-stockholdersagr002.jpg	Edgar Link	pending
electriq-stockholdersagr003.jpg	Edgar Link	pending
electriq-stockholdersagr004.jpg	Edgar Link	pending
electriq-stockholdersagr005.jpg	Edgar Link	pending
electriq-stockholdersagr006.jpg	Edgar Link	pending
electriq-stockholdersagr007.jpg	Edgar Link	pending
electriq-stockholdersagr008.jpg	Edgar Link	pending
electriq-stockholdersagr009.jpg	Edgar Link	pending
electriq-stockholdersagr010.jpg	Edgar Link	pending
electriq-stockholdersagr011.jpg	Edgar Link	pending
electriq-stockholdersagr012.jpg	Edgar Link	pending
electriq-stockholdersagr013.jpg	Edgar Link	pending
electriq-stockholdersagr014.jpg	Edgar Link	pending
electriq-stockholdersagr015.jpg	Edgar Link	pending
electriq-stockholdersagr016.jpg	Edgar Link	pending
electriq-stockholdersagr017.jpg	Edgar Link	pending
electriq-stockholdersagr018.jpg	Edgar Link	pending
electriq-stockholdersagr019.jpg	Edgar Link	pending
electriq-stockholdersagr020.jpg	Edgar Link	pending
electriq-stockholdersagr021.jpg	Edgar Link	pending
electriq-stockholdersagr022.jpg	Edgar Link	pending
electriq-stockholdersagr023.jpg	Edgar Link	pending
electriqpower-certificat.htm	Edgar Link	pending
electriqpower-certificat001.jpg	Edgar Link	pending
electriqpower-certificat002.jpg	Edgar Link	pending
electriqpower-certificat003.jpg	Edgar Link	pending
electriqpower-certificat004.jpg	Edgar Link	pending
electriqpower-certificat005.jpg	Edgar Link	pending
electriqpower-certificat006.jpg	Edgar Link	pending
electriqpower-certificat007.jpg	Edgar Link	pending
electriqpower-certificat008.jpg	Edgar Link	pending
electriqpower-certificat009.jpg	Edgar Link	pending
eliq-meteoraxbindingtermsh.htm	Edgar Link	pending
eltq-20230930.htm	Edgar Link	pending
eltq-20230930.xsd	Edgar Link	pending
exhibit1018-resalesx1.htm	Edgar Link	pending
exhibit1019-resalesx1.htm	Edgar Link	pending
exhibit1020-resalesx1.htm	Edgar Link	pending
exhibit1021-resalesx1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
phoenix-amendmentno1tolo.htm	Edgar Link	pending
phoenix-amendmentno1tolo001.jpg	Edgar Link	pending
phoenix-amendmentno1tolo002.jpg	Edgar Link	pending
phoenix-amendmentno1tolo003.jpg	Edgar Link	pending
phoenix-amendmentno1tolo004.jpg	Edgar Link	pending
phoenix-amendmentno1tolo005.jpg	Edgar Link	pending
phoenix-amendmentno1tolo006.jpg	Edgar Link	pending
phoenix-amendmentno1tolo007.jpg	Edgar Link	pending
phoenix-amendmentno1tolo008.jpg	Edgar Link	pending
phoenix-amendmentno1tolo009.jpg	Edgar Link	pending
phoenix-amendmentno1tolo010.jpg	Edgar Link	pending
phoenix-amendmentno1tolo011.jpg	Edgar Link	pending
phoenix-amendmentno1tolo012.jpg	Edgar Link	pending
phoenix-amendmentno1tolo013.jpg	Edgar Link	pending
phoenix-amendmentno1tolo014.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
eltq-20230930_pre.xml	Edgar Link	unprocessable
eltq-20230930_def.xml	Edgar Link	unprocessable
eltq-20230930_htm.xml	Edgar Link	completed
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ELIQQ
Electriq Power Holdings, Inc. Stock $eliqq

2023 Q4 Form 10-Q Financial Statement

#000162828023038999 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELIQQ Electriq Power Holdings, Inc. Stock $eliqq

2023 Q4 Form 10-Q Financial Statement

#000162828023038999 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELIQQ
Electriq Power Holdings, Inc. Stock $eliqq